| DB ID | MyCo_7151 |
| Title | Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies |
| Year | 2017 |
| PMID | 28576596 |
| Fungal Diseases involved | Invasive pulmonary aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | Hematological malignancies |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | None |
| Site of Infection | Unspecified |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Bronchoalveolar lavage fluid (BALF) |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | TAFC |
| Biomarker Full Name | Triacetylfusarinine C |
| Biomarker Type | Diagnostic |
| Biomolecule | Siderophore |
| Geographical Location | Austria |
| Cohort | A total of 45 BALF samples obtained from 45 patients with underlying hematological malignancies (15 patients with proven or probable IA and 30 controls with no IPA who were each matched 2:1 by age and underlying diseases) were included in this analysis. |
| Cohort No. | 15 Patients and 30 control |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | 1 |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | ELISA |
| Technique | Immunoassay |
| Analysis Method | Serum GM Platelia assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | None |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
